Analyst Ratings for Travere Therapeutics (TVTX)
TVTX Rating Summary
TVTX Price Target Summary
- Highest: $49.00 (Guggenheim)
- Lowest: $31.00 (Stifel)
- Average: $39.40
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$39.40 (+44.6%)
* Over Last 12-Mos
Rating Score: 7.3 / 10
Percentile Rank: 77%
Avg. $ Target:
$39.40 (+44.6%)
* Over Last 12-Mos
Rating Score: 7.3 / 10
Percentile Rank: 77%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/25/2025 | Evercore ISI » Updated 10/1/2025 |
Gavin Clark-Gartner | New Coverage | Outperform (N/A) |
35.00 (45.00) |
17.92 (27.24) |
52.01% | Details |
| 6/11/2025 | H.C. Wainwright » Updated 9/22/2025 |
Joseph Pantginis | New Coverage | Buy (N/A) |
47.00 (N/A) |
15.13 (27.24) |
80.04% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
